MDT
Income statement / Annual
Last year (2024), Medtronic plc's total revenue was $32.36 B,
an increase of 3.64% from the previous year.
In 2024, Medtronic plc's net income was $3.68 B.
See Medtronic plc’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
04/26/2024 |
04/28/2023 |
04/29/2022 |
04/30/2021 |
04/24/2020 |
04/26/2019 |
04/27/2018 |
04/28/2017 |
04/29/2016 |
04/24/2015 |
| Operating Revenue |
$32.36 B
|
$31.23 B
|
$31.69 B
|
$30.12 B
|
$28.91 B
|
$30.56 B
|
$29.95 B
|
$29.71 B
|
$28.83 B
|
$20.26 B
|
| Cost of Revenue |
$12.91 B |
$10.72 B |
$10.15 B |
$10.48 B |
$9.42 B |
$9.16 B |
$9.06 B |
$9.29 B |
$9.14 B |
$6.31 B |
| Gross Profit |
$19.45 B |
$20.51 B |
$21.54 B |
$19.63 B |
$19.49 B |
$21.40 B |
$20.90 B |
$20.42 B |
$19.69 B |
$13.95 B |
| Gross Profit Ratio |
0.6 |
0.66 |
0.68 |
0.65 |
0.67 |
0.7 |
0.7 |
0.69 |
0.68 |
0.69 |
| Research and Development
Expenses |
$2.74 B
|
$2.70 B
|
$2.75 B
|
$2.49 B
|
$2.33 B
|
$2.33 B
|
$2.25 B
|
$2.19 B
|
$2.22 B
|
$1.64 B
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$10.62 B
|
$10.42 B
|
$10.29 B
|
$10.15 B
|
$10.11 B
|
$10.42 B
|
$9.97 B
|
$9.71 B
|
$9.47 B
|
$6.90 B
|
| Other Expenses |
-$364.00 M |
$1.57 B |
$2.60 B |
$2.10 B |
$1.83 B |
$373.00 M |
$2.33 B |
$2.20 B |
$2.04 B |
$851.00 M |
| Operating Expenses |
$13.72 B |
$14.68 B |
$15.63 B |
$14.74 B |
$14.27 B |
$14.77 B |
$14.56 B |
$14.11 B |
$13.73 B |
$9.40 B |
| Cost And Expenses |
$26.63 B |
$25.40 B |
$25.78 B |
$25.22 B |
$23.69 B |
$23.93 B |
$23.61 B |
$23.40 B |
$22.87 B |
$15.70 B |
| Interest Income |
$0.00 |
$386.00 M |
$367.00 M |
$192.00 M |
$300.00 M |
$1.44 B |
$397.00 M |
$366.00 M |
$431.00 M |
$386.00 M |
| Interest Expense |
$719.00 M |
$636.00 M |
$553.00 M |
$925.00 M |
$1.09 B |
$1.44 B |
$1.15 B |
$1.09 B |
$1.39 B |
$666.00 M |
| Depreciation &
Amortization |
$2.65 B
|
$2.70 B
|
$2.71 B
|
$2.70 B
|
$2.66 B
|
$2.66 B
|
$2.64 B
|
$2.92 B
|
$2.82 B
|
$1.31 B
|
| EBITDA |
$8.38 B
|
$9.04 B
|
$8.93 B
|
$7.93 B
|
$8.24 B
|
$9.66 B
|
$9.38 B
|
$9.60 B
|
$9.21 B
|
$6.25 B
|
| EBITDA Ratio |
0.26 |
0.29 |
0.28 |
0.26 |
0.29 |
0.32 |
0.31 |
0.32 |
0.32 |
0.31 |
| Operating Income Ratio
|
0.18
|
0.18
|
0.18
|
0.15
|
0.17
|
0.21
|
0.22
|
0.18
|
0.18
|
0.19
|
| Total Other
Income/Expenses Net |
-$895.00 M
|
-$121.00 M
|
-$235.00 M
|
-$589.00 M
|
-$736.00 M
|
$9.00 M
|
$81.00 M
|
-$983.00 M
|
-$669.00 M
|
-$791.00 M
|
| Income Before Tax |
$4.84 B |
$5.36 B |
$5.52 B |
$3.90 B |
$4.06 B |
$5.20 B |
$5.68 B |
$4.60 B |
$4.34 B |
$3.49 B |
| Income Before Tax Ratio
|
0.15
|
0.17
|
0.17
|
0.13
|
0.14
|
0.17
|
0.19
|
0.15
|
0.15
|
0.17
|
| Income Tax Expense |
$1.13 B |
$1.58 B |
$456.00 M |
$265.00 M |
-$751.00 M |
$547.00 M |
$2.58 B |
$578.00 M |
$798.00 M |
$811.00 M |
| Net Income |
$3.68 B |
$3.76 B |
$5.04 B |
$3.61 B |
$4.79 B |
$4.63 B |
$3.10 B |
$4.03 B |
$3.54 B |
$2.68 B |
| Net Income Ratio |
0.11 |
0.12 |
0.16 |
0.12 |
0.17 |
0.15 |
0.1 |
0.14 |
0.12 |
0.13 |
| EPS |
2.77 |
2.83 |
3.75 |
2.68 |
3.57 |
3.44 |
2.29 |
2.92 |
2.51 |
2.44 |
| EPS Diluted |
2.76 |
2.82 |
3.73 |
2.66 |
3.54 |
3.41 |
2.27 |
2.89 |
2.48 |
2.41 |
| Weighted Average Shares
Out |
$1.33 B
|
$1.33 B
|
$1.34 B
|
$1.34 B
|
$1.34 B
|
$1.35 B
|
$1.36 B
|
$1.38 B
|
$1.41 B
|
$1.10 B
|
| Weighted Average Shares
Out Diluted |
$1.33 B
|
$1.33 B
|
$1.35 B
|
$1.35 B
|
$1.35 B
|
$1.36 B
|
$1.37 B
|
$1.39 B
|
$1.43 B
|
$1.11 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
